Subscribe to RSS
DOI: 10.1055/s-0029-1243623
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York
Glycaemic Control is Correlated with Well-Being Index (WHO-5) in Subjects with Type 2 Diabetes
Publication History
received 05.10.2009
first decision 22.11.2009
accepted 02.12.2009
Publication Date:
05 February 2010 (online)
Abstract
The aim of this study was to examine the potential correlation of WHO-5 well-being index with glycaemic control and chronic complications in subjects with type 2 diabetes. The study included 156 subjects (73 men, mean age 64.05±9.11 years, mean diabetes duration 12.22±5.61 years). Well-being was assessed by the WHO-5 score via a validated questionnaire comprising 5 questions (Q1-Q5). HbA1c showed a significant negative correlation with overall WHO-5 score (rs=−0.248, p=0.002) and individual Q1–Q4 scores (rs=−0.262, p=0.001; rs=−0.248, p=0.002; rs=−0.207, p=0.009 and rs=−0.169, p=0.035 respectively). Subjects with adequate glycaemic control (HbA1c < 7%, n=67) had a significantly higher WHO-5 score in comparison to those with inadequate glycaemic control (HbA1c ≥ 7%, n=89) (mean±SD: 19.69±5.47 vs. mean±SD: 17.11±6.38, p=0.011). Finally, WHO-5 score was significantly (p=0.013) lower in subjects with neuropathic pain than in those without neuropathic pain. Conclusions: In type 2 diabetic subjects, glycaemic control shows a significant correlation with well-being, while neuropathic pain is associated with lower well-being score.
Key words
diabetes mellitus - quality of life - glycaemic control - WHO-5 - neuropathic pain
References
- 1 Apostolou T, Hutchison AJ, Boulton AJ. et al . Quality of life in CAPD, transplant, and chronic renal failure patients with diabetes. Ren Fail. 2007; 29 189-197
- 2 Armstrong DG, Lavery LA, Wrobel JS. et al . Quality of life in healing diabetic wounds: does the end justify the means?. J Foot Ankle Surg. 2008; 47 278-282
- 3 Awata S, Bech P, Yoshida S. et al . Reliability and validity of the Japanese version of the World Health Organization-Five Well-Being Index in the context of detecting depression in diabetic patients. Psychiatry Clin Neurosci. 2007; 61 112-119
- 4 Bech P, Olsen LR, Kjoller M. et al . Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res. 2003; 12 85-91
- 5 Blackburn H, Keys A, Simonson E. et al . The electrocardiogram in population studies. A classification system. Circulation. 1960; 21 1160-1175
- 6 Bloomgarden ZT. Diabetes complications. Diabetes Care. 2004; 27 1506-1514
- 7 Bloomgarden ZT. Cardiovascular disease in diabetes. Diabetes Care. 2008; 31 1260-1266
- 8 Chobanian AV, Bakris GL, Black HR. et al . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289 2560-2572
- 9 de Wit M, Pouwer F, Gemke RJ. et al . Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes. Diabetes Care. 2007; 30 2003-2006
- 10 de Wit M, Delemarre-van de Waal HA, Bokma JA. et al . Self-report and parent-report of physical and psychosocial well-being in Dutch adolescents with type 1 diabetes in relation to glycemic control. Health Qual Life Outcomes. 2007b; 5 10
- 11 Eren I, Erdi O, Sahin M. The effect of depression on quality of life of patients with type II diabetes mellitus. Depress Anxiety. 2008; 25 98-106
- 12 Fong DS, Aiello L, Gardner TW. et al . Diabetic retinopathy. Diabetes Care. 2003; 26 ((Suppl 1)) S99-S102
- 13 Garber AJ, Wahlen J, Wahl T. et al . Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab. 2006; 8 58-66
- 14 Garratt AM, Schmidt L, Fitzpatrick R. Patient-assessed health outcome measures for diabetes: a structured review. Diabet Med. 2002; 19 1-11
- 15 Goykhman S, Drincic A, Desmangles JC. et al . Insulin Glargine: a review 8 years after its introduction. Expert Opin Pharmacother. 2009; 10 705-718
- 16 Gumprecht J, Benroubi M, Borzi V. et al . Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study. Int J Clin Pract. 2009; 63 966-972
- 17 Hajos TRS, Pouwer F, de Grooth R. et al . Improves symptom distress and well-being following initiation of insulin glargine in suboptimally controlled type 2 diabetes patients on oral agents. An observational study. Diabetologia. 2009; 52 ((Suppl 1)) A 973
- 18 Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet. 2004; 363 1589-1597
- 19 Klein S, Hage JJ. Measurement, calculation, and normal range of the ankle-arm index: a bibliometric analysis and recommendation for standardization. Ann Vasc Surg. 2006; 20 282-292
- 20 Logtenberg SJ, van Ballegooie E, Israel-Bultman H. et al . Glycaemic control, health status and treatment satisfaction with continuous intraperitoneal insulin infusion. Neth J Med. 2007; 65 65-70
- 21 Molitch ME, DeFronzo RA, Franz MJ. et al . Diabetic nephropathy. Diabetes Care. 2003; 26 ((Suppl 1)) S94-S98
- 22 Papanas N, Papatheodorou K, Papazoglou D. et al . Foot temperature in type 2 diabetic patients with or without peripheral neuropathy. Exp Clin Endocrinol Diabetes. 2009; 117 44-47
- 23 Rosen RC, Riley A, Wagner G. et al . The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49 822-830
- 24 Shea S, Skovlund S, Bech P. et al . Routine assessment of psychological well-being in people with diabetes in primary care – validation of the WHO-5-Well-being-Index in six countries. Diabetologia. 2003; 46 A88
- 25 Tan SM, Shafiee Z, Wu LL. et al . Factors associated with control of type I diabetes in Malaysian adolescents and young adults. Int J Psychiatry Med. 2005; 35 123-136
- 26 Tsapas A, Matthews DR. N of 1 trials in diabetes: making individual therapeutic decisions. Diabetologia. 2008; 51 921-925
- 27 Vileikyte L, Peyrot M, Bundy C. et al . The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care. 2003; 26 2549-2555
- 28 Vileikyte L, Leventhal H, Gonzalez JS. et al . Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care. 2005; 28 2378-2383
- 29 Vileikyte L, Peyrot M, Gonzalez JS. et al . Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia. 2009; 52 1265-1273
- 30 Wild S, Roglic G, Green A. et al . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27 1047-1053
- 31 Winkley K, Ismail K, Landau S. et al . Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ. 2006; 333 65
- 32 Young MJ, Boulton AJ, MacLeod AF. et al . A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993; 36 150-154
- 33 Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev. 2008; 24 ((Suppl 1)) S52-S57
Correspondence
Dr. N. Papanas
Democritus University of Thrace
68100 Alexandroupolis
Greece
Phone: +30 6977 544337
Fax: +30 25510 74723
Email: papanasnikos@yahoo.gr